We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

53 hedge funds and large institutions have $20.5M invested in ENZON PHARMACEUTICALS INC in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less capital invested

Capital invested by funds: $21.1M → $20.5M (-$656K)

7% less funds holding

Funds holding: 57 → 53 (-4)

31% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 16

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
53
Holders Change
-4
Holders Change %
-7.02%
% of All Funds
1.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
11
Reduced
16
Closed
7
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$392K
2
AWW
Alan W. Weber
+$217K
3
Deutsche Bank
Deutsche Bank
Germany
+$59.2K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$48.8K
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
+$33.3K

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$343K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$180K
3
Two Sigma Investments
Two Sigma Investments
New York
-$130K
4
BIT
BlackRock Institutional Trust
California
-$97.6K
5
Goldman Sachs
Goldman Sachs
New York
-$61.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$85K -$38K -36,709 -31%
CS
27
Credit Suisse
Switzerland
$85K -$16.4K -15,900 -17%
VKH
28
Virtu KCG Holdings
New York
$66K +$7.7K +7,443 +13%
Deutsche Bank
29
Deutsche Bank
Germany
$60K +$59.2K +57,249 +13,631%
RCM
30
Rotella Capital Management
Washington
$57K +$17.5K +16,926 +46%
Tudor Investment Corp
31
Tudor Investment Corp
Connecticut
$51K – – –
KBC Group
32
KBC Group
Belgium
$45K -$10.5K -10,182 -19%
BJ
33
BlackRock Japan
Japan
$37K – – –
State Street
34
State Street
Massachusetts
$30K -$4.43K -4,285 -13%
FPA
35
First Pacific Advisors
California
$25K – – –
Charles Schwab
36
Charles Schwab
California
$23K – – –
TSS
37
Two Sigma Securities
New York
$20K +$19.2K +18,608 New
JIR
38
James Investment Research
Ohio
$20K +$19.3K +18,640 New
Ameriprise
39
Ameriprise
Minnesota
$16K -$1.4K -1,357 -8%
MCM
40
Monarch Capital Management
Indiana
$11K – – –
SCP
41
Seizert Capital Partners
Michigan
$11K – – –
TRCT
42
Tower Research Capital (TRC)
New York
$10K -$12.4K -12,017 -56%
Federated Hermes
43
Federated Hermes
Pennsylvania
$10K – – –
CFA
44
CT Financial Advisors
Pennsylvania
$2.12K -$1.02K -990 -33%
Group One Trading
45
Group One Trading
Illinois
$2K -$103 -100 -5%
KTC
46
Kistler-Tiffany Companies
Pennsylvania
$1K – – –
WT
47
Whittier Trust
California
$1K – – –
Wells Fargo
48
Wells Fargo
California
$1K +$1 +1 +0.1%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 – – –
Invesco
50
Invesco
Georgia
– -$343K -314,907 Closed
1
2
3

ENZN Hedge Fund Activity: Q1 2015 in Review

53 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q1 2015, worth a combined $20.5M — down 3.1% from $21.1M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ENZN and 3 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 11 added.

The largest buyer was Renaissance Technologies, adding an estimated $392K. The largest seller was Invesco, exiting entirely with an estimated $343K sold.

  • 53 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q1 2015, down from 57 in Q4 2014.
  • Funds reported $20.5M of ENZON PHARMACEUTICALS INC stock for Q1 2015, down 3.1% quarter-over-quarter.
  • 3 funds opened new ENZON PHARMACEUTICALS INC positions in Q1 2015 and 7 closed out, a net change of -4 holders.
  • The largest ENZON PHARMACEUTICALS INC buyer in Q1 2015 was Renaissance Technologies, an estimated $392K added.
  • The largest ENZON PHARMACEUTICALS INC seller in Q1 2015 was Invesco, an estimated $343K sold.

Based on aggregated 13F filings for Q1 2015.